MétaCan
Menu
Back to cohort
Record W7126048515 · doi:10.1080/17576180.2025.2599698

2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot & FluoroSpot Best Practices; Modular HD Cytometry; Single-cell Analysis Imaging Cytometry (PART 2A – Recommendations on Biomarkers Discovery, Development, Validation & Regulatory Approval, Ligand-Binding Assays (LBA) and Cell-Based Assays (CBA) PART 2B – Regulatory Agencies’ Input on Biomarkers, IVD/CDx and Biomarker Assay Validation (BAV))

2025· article· en· W7126048515 on OpenAlexafffund
Sarah Hersey, Kristina McGuire, Nicoletta Bivi, Abbas Bandukwala, Binsheng Gong, Chad R. Irwin, Soma Ray, Michele Gunsior, Andrei Avanesov, Brian Baker, Sarah Bond, Alexander Braun, Alessandra Buoninfante, Francis Dessy, Xiaodong Fang, Fabio Garofolo, Emily Gomme, Amanda Hays, Lindsay King, Christian Mayer, Jessica McGregor, Melis McHenry, Anna Nowocin, Carrie E. Rubel, G C H Sanderink, Bradley J. Scott, Ingrid L. Scully, A. Seyda, Jeroen Stoop, Huaping Tang, João Tavares Neto, Karl Walravens, K Wang, W C Xiao, Liang Zhu, Jad Zoghbi, Catherine L Brockus, Corinne Petit-Frere, Kelly Coble, Sally Fischer, Graham Yearwood, Liching Cao, Mark Dysinger, Christine Grimaldi, Yong Jiang, Alison Joyce, Claire Kerridge, Kun Lu, Fred McCush, Katrina M. Nolan, Ellen O’ Connor, Rachel Palmer, Kimberly J. Reese, Kay‐Gunnar Stubenrauch, Thorsten Verch, Christopher Beaver, Luis Mendez, Vilma Decman, Kamala Bhavaraju, James W. Huleatt, Paul C. Trampont, Steven Eck, Polina Goihberg, Enrique Gómez Alcaide, Michael N. Hedrick, Rashmi Jalah, Shannon McGrath, William Ogorman, Sandra Prior, Sarita Sehra, Saleem Shaik, Nathan Standifer, Chad Stevens, Erin Stevens, Yongliang Sun

Bibliographic record

VenueBioanalysis · 2025
Typearticle
Languageen
FieldImmunology and Microbiology
TopicBiosimilars and Bioanalytical Methods
Canadian institutionsHealth Canada
FundersAgenzia Italiana del Farmaco, Ministero della SaluteHealth CanadaEisaiU.S. Food and Drug AdministrationModernaRegeneron PharmaceuticalsAlnylam PharmaceuticalsAlexion PharmaceuticalsDaiichi Sankyo EuropeExelixisGlaxoSmithKlinePfizerAstraZenecaEli Lilly and CompanyBristol-Myers Squibb
KeywordsWhite paperExcellenceHarmonizationAgency (philosophy)BioanalysisBest practiceQuality (philosophy)Expert opinion

Abstract

fetched live from OpenAlex

The 19th Workshop on Recent Issues in Bioanalysis (19th WRIB) took place in New Orleans, LA, USA on April 7-11, 2025. Over 1200 professionals representing pharma/biotech companies, CROs, and multiple regulatory agencies convened to actively discuss the most current topics of interest in bioanalysis. The 19th WRIB included 3 Main Workshops and 7 Specialized Workshops that together spanned 1 week to allow an exhaustive and thorough coverage of all major issues in bioanalysis of biomarkers, immunogenicity, gene therapy, cell therapy and vaccines.Moreover, in-depth workshops on “Implementation Practice for the Newest ELN/LIMS Systems” and on “Vaccine Cell-Based/Functional & Molecular Assays as part of the harmonization of vaccine clinical assays global initiative” were the special features of the 19th edition.As in previous years, WRIB continued to gather a wide diversity of international, industry opinion leaders and Regulatory Agency experts working on both small and large molecules as well as gene, cell therapies and vaccines to facilitate sharing and discussions focused on improving quality, increasing regulatory compliance, and achieving scientific excellence on bioanalytical issues.This 2025 White Paper encompasses recommendations emerging from the extensive discussions held during the workshop and is aimed to provide the bioanalytical community with key information and practical solutions on topics and issues addressed, in an effort to enable advances in scientific excellence, improved quality and better regulatory compliance. Due to its length, the 2025 edition of this comprehensive White Paper has been divided into three parts for editorial reasons.This publication (Part 2) covers in the Part 2A the recommendations on Biomarkers/BAV, IVD/CDx, Ligand-Binding Assays and Cell-Based Assays and in Part 3B the Regulatory Inputs on these topics. Part 1 (Mass Spectrometry Assays and Regulated Bioanalysis/BMV) and Part 3 (Gene Therapy, Cell therapy, Vaccines and Biotherapeutics Immunogenicity) are published in volume 18 of Bioanalysis, issues 3 and 1 (2026), respectively.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.011
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.070
Threshold uncertainty score0.236

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.011
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.002
Science and technology studies0.0020.002
Scholarly communication0.0090.004
Open science0.0040.002
Research integrity0.0120.007
Insufficient payload (model declined to judge)0.0700.066

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.095
GPT teacher head0.346
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueBioanalysisSame topicBiosimilars and Bioanalytical MethodsFrench-language works237,207